A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Herpes Zoster

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01873365

200089

Details and patient eligibility

About

The study aims to estimate the incidence of herpes zoster (HZ), proportion of postherpetic neuralgia (PHN) and the economic burden and impact on quality of life, in Japanese adults greater than or equal to sixty years of age.

Enrollment: 448 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.

• Written informed consent obtained from the subject.

• A male or female greater than or equal to sixty years of age, presenting with HZ at the time of enrollment.

• HZ diagnosis.

  • Is the subject's first outpatient diagnosis for this HZ episode. OR
  • Took place up to seven days prior to the initial visit for the present study. Note: Recurrent HZ cases may be enrolled as new cases based on the investigator's clinical practice.

Exclusion criteria

• Not applicable.

Trial design

448 participants in 1 patient group

Prospective Group

Description:

Japanese adults, aged greater than or equal to sixty years, diagnosed with HZ.

Treatment:

Other: Data collection